Stay updated with breaking news from சமி ஷண்முகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Copy shortlink: ANI Pharmaceuticals, the Baudette-based maker of generic and specialty drugs, announced plans to acquire Novitium Pharma in a $163.5 million deal that should increase its drug-commercialization capabilities. Strengthening our well-established generics business with enhanced development capabilities and increased focus on niche opportunities is a key pillar of ANI s growth strategy, Nikhil Lalwani, ANI s chief executive, said in a statement. Novitium, based in East Windsor, N.J., makes niche generic products in liquid, capsule, tablet and powder forms. It has a 50,000-square-foot facility for manufacturing and research and is adding 20,000 square feet to it. Lalwani said the state-of-the-art manufacturing facility is a key attraction in the deal. He also said ANI would be able to add more size to its contract development and manufacturing business. ....